Results 71 to 80 of about 48,920 (278)
Acinetobacter baumannii is currently a serious threat to human health, especially to people with immunodeficiency as well as patients with prolonged hospital stays and those undergoing invasive medical procedures.
Natalia Bagińska +8 more
doaj +1 more source
Bacteriophage and Phage-Therapy: An Alternative to Antibiotics
Bacteriophages are known for a century but their use in therapy to cure bacterial infection is still unknown. The working on bacteriophage investigation started about a century ago with their discovery by the English microbiologist Twort in 1915.
Soumya Srivastava*, Shruti Sinha
core +1 more source
BACTERIOPHAGE THERAPY AS A TREATMENT STRATEGY FOR ORTHOPAEDIC-DEVICE-RELATED INFECTIONS: WHERE DO WE STAND? [PDF]
Antibiotic resistance represents a key challenge of the 21st century. Since the pipeline of new antibiotics in development is limited, the introduction of alternative antimicrobial strategies is urgently required.
Metsemakers W. -J. +22 more
core +1 more source
Optimization of B Cell Responses in Human Immune System Mice Through Organoid Based Screening
Human immune system (HIS) mice show limited B cell responses to immunization. Using HIS mouse spleen organoids, this study identifies cytokine combinations and innate immune signals that drive human B cell expansion, differentiation, and class‐switch. Applying these signals in vivo through temporal separation enables antigen‐specific IgG responses and ...
Haiqiao Sun +6 more
wiley +1 more source
Phage therapy has emerged as a potential novel treatment of sepsis for which no decisive progress has been achieved thus far. Obviously, phages can help eradicate local bacterial infection and bacteremia that may occur in a syndrome.
Andrzej Górski +2 more
doaj +1 more source
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
The worldwide emergence of antibiotic resistances and the drying up of the antibiotic pipeline have spurred a search for alternative or complementary antibacterial therapies.
De Vos, Daniel +6 more
core +1 more source
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source
Safety Studies of Pneumococcal Endolysins Cpl-1 and Pal
Bacteriophage-derived endolysins have gained increasing attention as potent antimicrobial agents and numerous publications document the in vivo efficacy of these enzymes in various rodent models. However, little has been documented about their safety and
Marek Harhala +15 more
doaj +1 more source
Bacteriophage Therapy: Recent Developments and Applications of a Renaissance Weapon
The spreading antibiotic resistance of bacteria is one of the most important challenges of modern medicine, and a search for methods that could replace conventional treatments of bacterial infections is urgently needed.
core +1 more source
What's Old Is New Again: Bacteriophage Therapy in the 21st Century. [PDF]
We highlight features associated with bacteriophage therapy that make it an attractive treatment option for multidrug-resistant infections and also discuss some of the challenges that need to be considered in the design and execution of clinical trials ...
Schooley, Robert T, Aslam, Saima
core +1 more source

